This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Open-angle Glaucoma or Ocular Hypertension
and you are
over 18
years old
This is a trial in the final phase before the treatment is released on the market.
Show me locations

The purpose

The purpose of this study is to describe the long-term safety of a fixed combination product containing an alternative preservative, dosed once daily for 12 months, in patients with open-angle glaucoma or ocular hypertension.

Provided treatments

  • Drug: Travoprost/Timolol Maleate Fixed Combination solution
Tris trial is registered with FDA with number: NCT00928590. The sponsor of the trial is Alcon Research and it is looking for 155 volunteers for the current phase.
Official trial title:
A Twelve-Month Open-Label Safety Study of Polyquaternium-Preserved DuoTrav APS Dosed Once Daily in Patients With Open-Angle Glaucoma or Ocular Hypertension